Highlights ► The decision to stop a driving test is a subjective one, that depends on the awareness of performance impairment and risk perception by either the driver or the instructor. ► The decision to stop a driving test is made after both treatment with CNS-drugs and placebo. ► Tests that are stopped can have ‘normal’ SDLP values, while tests with higher SDLP values may be completed. ► SDLP is a poor correlate of the decision to stop a driving test.

    Abstract Introduction and objectives The on-the-road driving test in normal traffic is applied to examine the impact of drugs on driving performance. Although participants are accompanied by a licensed driving instructor, under Dutch law, the driver is primarily responsible for safe driving and is not permitted to continue driving when it is judged that the drug compromises safety. This review examined the prevalence and nature of stopped driving tests, and the relationship with Standard Deviation of Lateral Position (SDLP), i.e. the “weaving of the car”. Materials and methods A literature search was conducted to gather all publications on clinical trials that applied the on-the-road driving test, examining the effects of Central Nervous System (CNS)-drugs such as anxiolytics, antidepressants, antihistamines, analgesics, and hypnotics. Results 47 papers reported on 50 Dutch clinical trials in which 1059 subjects participated (903 healthy volunteers and 156 patients). A total of 7232 driving tests were performed; 5050 after drug treatment and 2042 after placebo. 3.1% of all driving tests were terminated before completion: 4.1% after drug treatment, and 0.7% after placebo. The decision to stop a driving test was 3–4 times more often made by the driving instructor than the subject. The most common reasons for stopping were the driver feeling tired or sleepy, or the driving instructor noticing signs of drowsiness and performance impairment. Although SDLP values of stopped driving tests are sometimes high, there is no clear relationship between SDLP (changes from placebo) and the decision to stop a driving test. Based on 8 studies that reported exact data, 39.6% of stopped drivers had a lower and 60.4% had a higher SDLP than 35cm, i.e. the cut-off point of safe driving. This confirms that perception of the driver as well as judgment by the instructor of driving to be ‘unsafe’ differs between individuals. Conclusion Driving tests are sometimes stopped after drug treatment or placebo. The decision to stop driving is not a good correlate of objective performance.


    Access

    Check access

    Check availability in my library

    Order at Subito €


    Export, share and cite



    Title :

    The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment


    Contributors:

    Published in:

    Publication date :

    2011-09-01


    Size :

    9 pages




    Type of media :

    Article (Journal)


    Type of material :

    Electronic Resource


    Language :

    English





    Traffic delay due to bus stopped at road-side stop

    Myozin, S. | Engineering Index Backfile | 1966


    REDUCING INCONVENIENCE TO SURROUNDING ROAD USERS CAUSED BY STOPPED AUTONOMOUS VEHICLES

    DYER JOHN WESLEY / EPSTEIN MICHAEL / HU KEN | European Patent Office | 2021

    Free access

    REDUCING INCONVENIENCE TO SURROUNDING ROAD USERS CAUSED BY STOPPED AUTONOMOUS VEHICLES

    DYER JOHN WESLEY / EPSTEIN MICHAEL / HU KEN | European Patent Office | 2020

    Free access

    Reducing inconvenience to surrounding road users caused by stopped autonomous vehicles

    DYER JOHN WESLEY / EPSTEIN MICHAEL / HU KEN | European Patent Office | 2023

    Free access